Clinical rebleeding within 30 days
| OTSC (n=50) | Conventional (n=50) | P value | Effect size | 95% CI | |
| Rebleeding within 30 days, n (%) | 50 (10) | 9 (18) | 0.234 | 1.98 | 0.61 to 6.38 |
| Early rebleeding (within 72 hours) (%) | 2 (4) | 3 (6) | 1.00 | 1.53 | 0.25 to 9.59 |
| Death from all causes within 30 days of therapy (%) | 2 (4) | 4 (8) | 0.68 | 2.09 | 0.37 to 11.95 |
| Failure of achieving primary haemostasis (%) | 4 (8) | 2 (4) | 0.68 | 0.47 | 0.08 to 2.70 |
| Total blood transfusion (units) (mean (S.D.) | 3.13 (3.64) | 2.90 (4.07) | 0.31 | 0.10 | Nil |
| Hospital stay (days) (mean (S.D.) | 13.72 (24.33) | 13.27 (16.13) | 0.76 | 0.03 | Nil |
| ICU admission, n (%) | 3 (6) | 3 (6) | 1.00 | 1.00 | 0.19 to 5.21 |
| Further interventions | |||||
| TAE (%) | 3 (6) | 0/50 (0) | 0.24 | 0.18 | Nil |
| Surgery (%) | 0 (0) | 1/50 (2) | 1.00 | 0.10 | Nil |
ICU, intensive care unit; OTSC, over-the-scope clip; TAE, transarterial embolisation.